TYMS expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.465600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.360400E-01
Normal-vs-Stage2
4.993800E-01
Normal-vs-Stage3
5.943200E-01
Normal-vs-Stage4
8.235000E-01
Stage1-vs-Stage2
2.171200E-01
Stage1-vs-Stage3
4.742000E-01
Stage1-vs-Stage4
6.744400E-01
Stage2-vs-Stage3
8.710600E-01
Stage2-vs-Stage4
6.060800E-01
Stage3-vs-Stage4
7.804400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.372600E-01
Normal-vs-AfricanAmerican
8.285600E-01
Normal-vs-Asian
2.925000E-01
Caucasian-vs-AfricanAmerican
5.425600E-01
Caucasian-vs-Asian
8.654800E-01
AfricanAmerican-vs-Asian
3.718400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.739600E-01
Normal-vs-Female
4.270600E-01
Male-vs-Female
5.623800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.800400E-01
Normal-vs-Age(41-60Yrs)
4.465400E-01
Normal-vs-Age(61-80Yrs)
6.248600E-01
Normal-vs-Age(81-100Yrs)
4.117400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.565800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.817200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.629800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.567990E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.667000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.111000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.667000E-01
Normal-vs-Daily Drinker
8.261400E-01
Normal-vs-Weekly Drinker
4.991800E-01
Normal-vs-Occasional Drinker
3.926400E-01
Normal-vs-Social Drinker
5.629600E-01
Non Drinker-vs-Daily Drinker
1.892960E-01
Non Drinker-vs-Weekly Drinker
8.430600E-01
Non Drinker-vs-Occasional Drinker
6.982000E-01
Non Drinker-vs-Social Drinker
6.760600E-01
Daily Drinker-vs-Weekly Drinker
2.495600E-01
Daily Drinker-vs-Occasional Drinker
1.999000E-01
Daily Drinker-vs-Social Drinker
3.718800E-01
Weekly Drinker-vs-Occasional Drinker
8.996600E-01
Weekly Drinker-vs-Social Drinker
8.044600E-01
Occasional Drinker-vs-Social Drinker
8.602600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.615600E-01
Normal-vs-Grade 2
7.915800E-01
Normal-vs-Grade 3
8.421000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.660100E-03
Grade 1-vs-Grade 3
1.322520E-03
Grade 1-vs-Grade 4
6.615600E-01
Grade 2-vs-Grade 3
3.650800E-01
Grade 2-vs-Grade 4
7.915800E-01
Grade 3-vs-Grade 4
8.421000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.334600E-01
Normal-vs-NonDiabetic
5.076400E-01
Diabetic-vs-NonDiabetic
4.629800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.762010E-01
Normal-vs-NoPancreatitis
5.741600E-01
Pancreatitis-vs-NoPancreatitis
3.361200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.402000E-01
Normal-vs-N1
5.569600E-01
N0-vs-N1
5.611000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.628180E-01
Normal-vs-TP53-NonMutant
5.982400E-01
TP53-Mutant-vs-TP53-NonMutant
1.801210E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
